2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9620):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W134007S1
    Hexadecanoate-13C16 potassium
    		98.40%
    Hexadecanoate-13C16 (potassium) is the 13C-labeled Hexadecanoate sodium. Hexadecanoate potassium can induce the expression of glucose-regulated protein 78 (GRP78) and CCAAT/enhancer binding protein homologous protein (CHOP) in in mouse granulosa cells.
    Hexadecanoate-<sup>13</sup>C<sub>16</sub> potassium
  • HY-146929S
    18:1 SM (d18:1/18:1)-d9
    18:1 SM (d18:1/18:1)-d9 is deuterium labeled 18:1 SM (d18:1/18:1).
    18:1 SM (d18:1/18:1)-d<sub>9</sub>
  • HY-66011AS
    Moxifloxacin-d4
    Moxifloxacin-d4 is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
    Moxifloxacin-d<sub>4</sub>
  • HY-78131CS
    Ibuprofen-d3 sodium
    		≥99.0%
    Ibuprofen-d3 ((±)-Ibuprofen-d3) sodium is the deuterium labeled Ibuprofen sodium (HY-78131C). Ibuprofen sodium is an orally active, selective COX-1 inhibitor with an IC50 value of 13 μM. Ibuprofen sodium inhibits cell proliferation, angiogenesis, and induces cell apoptosis. Ibuprofen sodium is a nonsteroidal anti-inflammatory agent and a nitric oxide (NO) donor. Ibuprofen sodium can be used in the research of pain, swelling, inflammation, infection, immunology, cancers.
    Ibuprofen-d<sub>3</sub> sodium
  • HY-151911S
    Mono-Cyclohexyl Phthalate-3,4,5,6-d4
    		99.07%
    Mono-Cyclohexyl Phthalate-3,4,5,6-d4 is the deuterium labeled Mono-Cyclohexyl Phthalate.
    Mono-Cyclohexyl Phthalate-3,4,5,6-d<sub>4</sub>
  • HY-76082S1
    L-Pyroglutamic acid-13C5
    L-Pyroglutamic acid-13C5 is the 13C labeled L-Pyroglutamic acid (HY-76082). L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the levo-isomer of Pyroglutamic acid. L-Pyroglutamic acid is the biologically active enantiomer in humans. Pyroglutamic acid is an intermediate in glutathione metabolism. L-Pyroglutamic acid can be used as a biomarker for systemic lupus erythematosus (SLE).
    L-Pyroglutamic acid-<sup>13</sup>C<sub>5</sub>
  • HY-113254S1
    13,14-Dihydro-15-keto-PGE2-d9
    		≥99.0%
    13,14-Dihydro-15-keto-PGE2-d9 is the deuterium labeled 13,14-Dihydro-15-keto-PGE2.
    13,14-Dihydro-15-keto-PGE2-d<sub>9</sub>
  • HY-118774S
    Propofol-d17 β-D-glucuronide
    		≥98.0%
    Propofol-d17 β-D-glucuronide is the deuterium labeled Propofol β-D-glucuronide.
    Propofol-d<sub>17</sub> β-D-glucuronide
  • HY-W014633S
    4-(Trifluoromethoxy)benzoic acid-d4
    		99.60%
    4-(Trifluoromethoxy)benzoic acid-d4 is the deuterium labeled 4-(Trifluoromethoxy)benzoic acid.
    4-(Trifluoromethoxy)benzoic acid-d<sub>4</sub>
  • HY-Y0194S
    2-Aminohexane-d6
    2-Aminohexane-d6 is the deuterium labeled 2-Aminohexane.
    2-Aminohexane-d<sub>6</sub>
  • HY-146795S
    15:0-18:1 DG-d7
    		≥99.0%
    15:0-18:1 DG-d7 is deuterium labeled 15:0-18:1 DG.
    15:0-18:1 DG-d<sub>7</sub>
  • HY-143922S
    N-Desmethyl Bedaquiline-d6
    N-Desmethyl Bedaquiline-d6 is the deuterium labeled N-Desmethyl Bedaquiline.
    N-Desmethyl Bedaquiline-d<sub>6</sub>
  • HY-50935S
    Troglitazone-d4
    		98.19%
    Troglitazone-d4 is deuterium labeled Troglitazone. Troglitazone is a PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine PPARγ receptor, respectively.
    Troglitazone-d<sub>4</sub>
  • HY-W017162S
    DL-3-Phenyllactic acid-d3
    DL-3-Phenyllactic acid-d3 is a deuterated labeled DL-3-Phenyllactic acid. DL-3-Phenyllactic acid is a broad-spectrum antimicrobial compound.
    DL-3-Phenyllactic acid-d<sub>3</sub>
  • HY-W131353S
    Hexatriacontane-d74
    		≥99.0%
    Hexatriacontane-d74 is the deuterium labeled Hexatriacontane.
    Hexatriacontane-d<sub>74</sub>
  • HY-12778S
    N-Demethyl Ivabradine-d6 hydrochloride
    		≥98.0%
    N-Demethyl Ivabradine-d6 (hydrochloride) is the deuterium labeled N-Demethyl Ivabradine, which is a metabolite of Ivabradine.
    N-Demethyl Ivabradine-d<sub>6</sub> hydrochloride
  • HY-B0129S
    Aztreonam-d6
    		99.29%
    Aztreonam-d6 is deuterium labeled Aztreonam. Aztreonam (SQ-26,776) is a synthetic monocyclic beta-lactam antibiotic, which has a very high affinity for penicillin-binding protein 3 (PBP-3).
    Aztreonam-d<sub>6</sub>
  • HY-N7092S2
    D-Fructose-13C-1
    		≥98.0%
    D-Fructose-13C-1 is the 13C labeled D-Fructose. D-Fructose (D(-)-Fructose) is a naturally occurring monosaccharide found in many plants.
    D-Fructose-<sup>13</sup>C-1
  • HY-10163S
    Dabigatran-d4
    Dabigatran-d4 is deuterium labeled Dabigatran. Dabigatran (BIBR 953), an oral anticoagulant, is a reversible, potent, competitive direct thrombin inhibitor (Ki=4.5 nM). Dabigatran (BIBR 953) also inhibits thrombin-induced platelet aggregation (IC50=10 nM).
    Dabigatran-d<sub>4</sub>
  • HY-B1145S
    Chlorhexidine-d8 dihydrochloride
    Chlorhexidine-d8 (dihydrochloride) is the deuterium labeled Chlorhexidine dihydrochloride (HY-B1145). Chlorhexidine dihydrochloride is a orally active cationic antimicrobial agent that targets microbial cell membranes. Chlorhexidine dihydrochloride binds to cell membrane phospholipids non-specifically, destroys membrane structure and induces leakage of cell contents. Chlorhexidine dihydrochloride has broad-spectrum bactericidal activity against both Gram-positive and Gram-negative bacteria. Chlorhexidine dihydrochloride can interfere with membrane permeability, cause protein precipitation and energy metabolism disorders, such as rapid inhibition of microbial growth and induction of cell death (necrosis or apoptosis).
    Chlorhexidine-d<sub>8</sub> dihydrochloride